text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 110429-36-2 | Product Number: M2645

N-Methyl Paroxetine

Purity: >98.0%(GC)(T)
18   2  
13   2  

* Please contact our distributors or TCI to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.

Product Number M2645
Purity / Analysis Method >98.0%(GC)(T)
Molecular Formula / Molecular Weight C__2__0H__2__2FNO__3 = 343.40  
Physical State (20 deg.C) Solid
Storage Temperature <0°C
Condition to Avoid Heat Sensitive
CAS RN 110429-36-2
Reaxys Registry Number 768178
PubChem Substance ID 253662337
MDL Number


Appearance White to Almost white powder to crystal
Purity(GC) min. 98.0 %
Purity(Nonaqueous Titration) min. 98.0 %
Melting point 109.0 to 113.0 °C
Specific rotation [a]20/D -69.0 to -89.0 deg(C=0.01, MeOH)
Properties (reference)
Melting Point 111 °C
Specific Rotation -70° (C=0.01,MeOH)
Pictogram Pictogram
Signal Word Warning
Hazard Statements H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
Precautionary Statements P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P302 + P352 : IF ON SKIN: Wash with plenty of water.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P362 + P364 : Take off contaminated clothing and wash it before reuse.
P332 + P313 : If skin irritation occurs: Get medical advice/ attention.
Related Laws:
Transport Information:
H.S.code* 2933.39-000
*This code is applied to the products when TCI exports from Japan and not for import in your country.
N-Methyl paroxetine: A Synthetic Precursor of Paroxetine

N-Methyl paroxetine is a synthetic precursor of paroxetine hydrochloride hemihydrate [P1977] which is a 5-hydroxytryptamine (5-HT) uptake inhibitor.


  • Preparation of crystalline paroxetine hydrochloride hemihydrate for use as an antidepressant
    • R. D. Barnes, M. W. Wood-Kaczmar, J. E. Richardson, I. R. Lynch, P. C. Buxton, A. D. Curzons, Eur. Pat. Appl. 1987, EP 223403 A2.
  • Preparation of paroxetine from N-alkyl derivatives.
    • S.-z. Wang, Y. Matsumura, Eur. Pat. Appl. 1997, EP 810225 A1.

PubMed Literature

Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents